SB-408124 is a drug which is a non-peptide antagonist selective for the orexin receptor subtype OX1 with around 70x selectivity for OX1 over OX2 receptors and improved oral bioavailability compared to the older OX1 antagonist SB-334867. It is used in scientific research into the function of orexinergic neurons in the body.
This page contains content from the copyrighted Wikipedia article "SB-408124"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
